Assessment of splenomegaly

References

Key articles

Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90.Full text  Abstract

Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008 Nov 15;112(10):3939-48.Full text  Abstract

Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008 Nov 15;112(10):3927-38.Full text  Abstract

Reference articles

1. Lichtin AE, Cook JR. Diseases of the spleen. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:697-705.

2. McKenzie CV, Colonne CK, Yeo JH, et al. Splenomegaly: pathophysiological bases and therapeutic options. Int J Biochem Cell Biol. 2017 Dec 2;94:40-3. Abstract

3. Sjoberg BP, Menias CO, Lubner MG, et al. Splenomegaly: a combined clinical and radiologic approach to the differential diagnosis. Gastroenterol Clin North Am. 2018 Sep;47(3):643-66. Abstract

4. Willner IR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2005 May;21(3):323-30. Abstract

5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology [internet publication].Full text

6. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: chronic lymphocytic leukemia/small lymphocytic lymphoma [internet publication].Full text

7. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long term follow-up of no initial therapy. J Clin Oncol. 2004 Apr 15;22(8):1454-9.Full text  Abstract

8. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas [internet publication].Full text

9. Koc O, Wilson WH. Non-Hodgkin's lymphoma. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:579-95.

10. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004 Nov 15;104(10):3009-20.Full text  Abstract

11. Gavriatopoulou M, Musto P, Caers J, et al. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia. 2018 Sep;32(9):1883-98. Abstract

12. Gertz MA. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017 Feb;92(2):209-17.Full text  Abstract

13. Frater JL. T-cell prolymphocytic leukemia: review of an entity and its differential diagnostic considerations. Int J Lab Hematol. 2020 Jun;42 Suppl 1:90-8. Abstract

14. Licata MJ, Janakiram M, Tan S, et al. Diagnostic challenges of adult T-cell leukemia/lymphoma in North America - a clinical, histological, and immunophenotypic correlation with a workflow proposal. Leuk Lymphoma. 2018 May;59(5):1188-94. Abstract

15. Kutok JL, Fletcher CD. Splenic vascular tumors. Semin Diagn Pathol. 2003 May;20(2):128-39. Abstract

16. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90.Full text  Abstract

17. Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008 Aug 7;359(6):575-83.Full text  Abstract

18. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: hairy cell leukemia [internet publication].Full text

19. Cortes JE, Talpaz M, O'Brien S, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006 Mar 15;106(6):1306-15. Abstract

20. Mughal TI, Goldman JM. Chronic myeloid leukemia: current status and controversies. Oncology. 2004 Jun;18(7):837-44. Abstract

21. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000 Apr 27;342(17):1255-65. Abstract

22. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: myeloproliferative neoplasms [internet publication].Full text

23. Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007 Jun 7;356(23):2361-71.Full text  Abstract

24. Jordan MB, Allen CE, Greenberg J, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019 Nov;66(11):e27929.Full text  Abstract

25. La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019 Jun 6;133(23):2465-77.Full text  Abstract

26. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007 Feb;48(2):124-31. Abstract

27. Grabowski GA. Recent clinical progress in Gaucher disease. Curr Opin Pediatr. 2005 Aug;17(4):519-24. Abstract

28. Imrie J, Vijayaraghaven S, Whitehouse C, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis. 2002 Oct;25(6):491-500. Abstract

29. Griffith KS, Lewis LS, Mali S, et al. Treatment of malaria in the United States: a systematic review. JAMA. 2007 May 23;297(20):2264-77. Abstract

30. Leoni S, Buonfrate D, Angheben A, et al. The hyper-reactive malarial splenomegaly: a systematic review of the literature. Malar J. 2015 Apr 29;14:185.Full text  Abstract

31. Kan FK, Tan CC, Von Bahr Greenwood T, et al. Dengue infection complicated by hemophagocytic lymphohistiocytosis: experiences from 180 patients with severe dengue. Clin Infect Dis. 2020 May 23;70(11):2247-55.Full text  Abstract

32. Giang HTN, Banno K, Minh LHN, et al. Dengue hemophagocytic syndrome: a systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors. Rev Med Virol. 2018 Nov;28(6):e2005. Abstract

33. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008 Nov 15;112(10):3939-48.Full text  Abstract

34. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008 Nov 15;112(10):3927-38.Full text  Abstract

35. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006 May 11;354(19):2034-45. Abstract

36. Shmueli H, Flint N, Pollick C, et al. Spleen size and appearance by transesophageal echocardiography in patients with suspected infective endocarditis. JACC Cardiovasc Imaging. 2020 Apr;13(4):1082-3.Full text  Abstract

37. Yung L, Linch D. Hodgkin's lymphoma. Lancet. 2003 Mar 15;361(9361):943-51. Abstract

38. Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Jul 30;108(9):1400-15.Full text  Abstract

39. American Society for Clinical Pathology. Choosing wisely: testing for amylase. Sep 2016 [internet publication].Full text

40. Cessford T, Meneilly GS, Arishenkoff S, et al. Comparing physical examination with sonographic versions of the same examination techniques for splenomegaly. J Ultrasound Med. 2018 Jul;37(7):1621-9. Abstract

41. Sigrist RMS, Liau J, Kaffas AE, et al. Ultrasound elastography: review of techniques and clinical applications. Theranostics. 2017;7(5):1303-29.Full text  Abstract

42. Gary SE, Ryan E, Steward AM, et al. Recent advances in the diagnosis and management of Gaucher disease. Expert Rev Endocrinol Metab. 2018 Mar;13(2):107-18.Full text  Abstract

43. Batur A, Alagoz S, Durmaz F, et al. Measurement of spleen stiffness by shear-wave elastography for prediction of splenomegaly etiology. Ultrasound Q. 2019 Jun;35(2):153-6. Abstract

44. İmamoğlu H, Zararsız G, Özdemir M, et al. The orthogonal measurements approach in estimating spleen size on CT images. Diagn Interv Radiol. 2020 Jan;26(1):5-10.Full text  Abstract

45. Indiran V, Vinod Singh N, Ramachandra Prasad T, et al. Does coronal oblique length of spleen on CT reflect splenic index? Abdom Radiol (NY). 2017 May;42(5):1444-8. Abstract

46. Kucybała I, Ciuk S, Tęczar J. Spleen enlargement assessment using computed tomography: which coefficient correlates the strongest with the real volume of the spleen? Abdom Radiol (NY). 2018 Sep;43(9):2455-61.Full text  Abstract

47. Gunes SO, Akturk Y. Determination of splenomegaly by coronal oblique length on CT. Jpn J Radiol. 2018 Feb;36(2):142-50. Abstract

48. Huo Y, Liu J, Xu Z, et al. Robust multicontrast MRI spleen segmentation for splenomegaly using multi-atlas segmentation. IEEE Trans Biomed Eng. 2018 Feb;65(2):336-43.Full text  Abstract

49. Huo Y, Xu Z, Bao S, et al. Splenomegaly segmentation on multi-modal MRI using deep convolutional networks. IEEE Trans Med Imaging. 2019 May;38(5):1185-96.Full text  Abstract

50. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 2019 Jan;94(1):133-43.Full text  Abstract

51. Cetin G, Ozkan T, Turgut S, et al. Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. Mol Biol Rep. 2014 Oct;41(10):6737-42. Abstract

52. Karaköse S, Oruç N, Zengin M, et al. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis. Turk J Gastroenterol. 2015 Jan;26(1):42-8.Full text  Abstract

53. Thurmes PJ, Steensma DP. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis. Eur J Haematol. 2006 Jul;77(1):57-60. Abstract

54. Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018 Nov 6;69(1):394-419.Full text  Abstract

55. Chapman MH, Thorburn D, Hirschfield GM, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019 Aug;68(8):1356-78.Full text  Abstract

56. Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.Full text  Abstract

57. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Dec 2021 [internet publication].Full text

58. National Institute for Health and Care Excellence. Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care. Jul 2017 [internet publication].Full text

59. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 Jul;112(7):1016-30.Full text  Abstract

60. Mehta A, Kuter DJ, Salek SS, et al. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Intern Med J. 2019 May;49(5):578-91.Full text  Abstract

61. Deshwal R. Clinical and laboratory profile of hospitalized malarial patients: an Agra-based study. J Assoc Physicians India. 2016 Aug;64(8):44-7.Full text  Abstract

62. Guo C, Zhou Z, Wen Z, et al. Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2017;7:317.Full text  Abstract

63. World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Oct 2009 [internet publication].Full text

64. Ferreira BDC, Correia D. Ultrasound assessment of hepatobiliary and splenic changes in patients with dengue and warning signs during the acute and recovery phases. J Ultrasound Med. 2019 Aug;38(8):2015-24. Abstract

Use of this content is subject to our disclaimer